ranbaxy laboratories - pharma stock analysis
DESCRIPTION
Analysis of the Ranbaxy Lab stock that is listed on BSE/NSE. Includes return ratios and piotroski scores to understand financial stability of the stocksTRANSCRIPT
Ranbaxy Laboratories
BSE Code : 500359
NSE Code : RANBAXY
Sector : PHARMACEUTICALSReport date : Sun Apr 13 10:42:01 EDT 2014
Industry overview
Market CapMarket Cap is the price ofall the outstandingcommon shares if we wereto buy it all at the currentprice
19828.62 Cr
The benchmark companySun Pharma in thepharmaceuticals sector is7 times the size ofRanbaxy Laboratories
Large Caps are a choicefor people who want Lowvolatility/risk with stablereturns and high liquidity
1
Stock AnalysisGrowth Analysis
Companies that have grown historically are more likely to exibit similar growth in the future. Read
the trends in the 4 year annualized profit growth, book value growth and sales growth shown
below:
How good are the returns?
RoE is the speed at which the company might grow without sorting to additional fund raising.
RoCE is the growth speed, if the company used all the assets, including loans/preference shares.
The 2-year and 4-year values give a reasonable assurance about the growth sustenance.
KEY
KEY
2
Piotroski ScoreSeperate Winners from Losers
The Piotroski scoring system is a nine point system to determine the strength of a firm's financial
position. The score was developed by an accounting professor out of Chicago named Joseph
Piotroski. If it scores an 8 or 9, then the fundamentals are great for the stock.
Score: 4/9
3